Not logged in Share Save
Share Save
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes Nicholls, Stephen J.; Pavo, Imre; Bhatt, Deepak L.; Buse, John B.; Del Prato, Stefano; Kahn, Steven E.; Lincoff, A. Michael; McGuire, Darren K.; Miller, Debra; Nauck, Michael A.; Nishiyama, Hiroshi; Nissen, Steven E.; Sattar, Naveed; Weerakkody, Govinda; Wiese, Russell J.; Zinman, Bernard; Zoungas, Sophia; Basile, Jan; Davies, Melanie J.; Giorgino, Francesco; Kellerer, Monika; Ji, Linong; Varkonyi, Tamas; Menon, Venu; Broder, Jonathan C.; Herschtal, Alan; D'Alessio, David Share Save
Share Save
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study Quast, Daniel R.; Xie, Cong; Bound, Michelle J.; Grivell, Jacqueline; Hatzinikolas, Seva; Jones, Karen L.; Horowitz, Michael; Rayner, Christopher K.; Nauck, Michael A.; Meier, Juris J.; Phillips, Liza K.; Wu, Tongzhi Share Save
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility Jalleh, Ryan J.; Marathe, Chinmay S.; Rayner, Christopher K.; Jones, Karen L.; Umapathysivam, Mahesh M.; Wu, Tongzhi; Quast, Daniel R.; Plummer, Mark P.; Nauck, Michael A.; Horowitz, Michael Share Save
Share Save
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide Jalleh, Ryan J.; Plummer, Mark P.; Marathe, Chinmay S.; Umapathysivam, Mahesh M.; Quast, Daniel R.; Rayner, Christopher K.; Jones, Karen L.; Wu, Tongzhi; Horowitz, Michael; Nauck, Michael A. Share Save
Share Save
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes Quast, Daniel R.; Lancaster, Dara; Xie, Cong; Bound, Michelle J.; Grivell, Jacqueline; Jones, Karen L.; Horowitz, Michael; Meier, Juris J.; Wu, Tongzhi; Rayner, Christopher K.; Nauck, Michael A. Share Save
Share Save
Share Save
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics Nicholls, Stephen J.; Bhatt, Deepak L.; Buse, John B.; Del Prato, Stefano; Kahn, Steven E.; Lincoff, A. Michael; McGuire, Darren K.; Nauck, Michael A.; Nissen, Steven E.; Sattar, Naveed; Zinman, Bernard; Zoungas, Sophia; Basile, Jan; Bartee, Amy; Miller, Debra; Nishiyama, Hiroshi; Pavo, Imre; Weerakkody, Govinda; Wiese, Russell J.; D'Alessio, David Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes Schnell, Oliver; Battelino, Tadej; Bergenstal, Richard; Birkenfeld, Andreas L.; Ceriello, Antonio; Cheng, Alice; Davies, Melanie; Edelman, Steve; Forst, Thomas; Giorgino, Francesco; Green, Jennifer; Groop, Per-Henrik; Hadjadj, Samy; Heerspink, Hiddo J. L.; Hompesch, Marcus; Izthak, Baruch; Ji, Linong; Kanumilli, Naresh; Mankovsky, Boris; Mathieu, Chantal; Miszon, Martin; Mustafa, Reem; Nauck, Michael; Pecoits-Filho, Roberto; Pettus, Jeremy; Ranta, Kari; Rodbard, Helena W.; Rossing, Peter; Ryden, Lars; Schumm-Draeger, Petra-Maria; Solomon, Scott D.; Skrha, Jan; Topsever, Pinar; Vilsboll, Tina; Wilding, John; Standl, Eberhard Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}